Status:
TERMINATED
Catheter Ablation Versus Thoracoscopic Ablation to Patients With Permanent Atrial Fibrillation
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Patents with atrial fibrillation can be treated with the purpose of curing the arrhythmia.This may be achieved by catheter ablation and Maze surgery where the latter includes open heart surgery. By c...
Detailed Description
Patients with permanent atrial fibrillation will be considered for randomisation Patients will be randomised to either conventional endocardial catheter ablation or epicardial thoracoscopic ablation. ...
Eligibility Criteria
Inclusion
- Permanent atrial fibrillation documented on at least 2 ecg´s with more than 1 month between ecg´s. The diagnosis is verified on Holter.
- All patients have symptoms or do not tolerate rate control treatment.
Exclusion
- Psychiatric disease or suspicion of incapability to give informed concent
- Females with birth giving potential
- Previous heart surgery
- Previous ablation for atrial fibrillation
- Life expectance less than 1 year
- Congenital heart disease
- Expected need for heart surgery
- Heart failure (NYHA class IV)
- Inability to be treated with anticoagulation
- In case of previous deep venous thromboembolism og stroke the investigators will individually consider if the patient is suitable for inclusion.
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2010
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00296166
Start Date
November 1 2006
End Date
November 1 2010
Last Update
September 2 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Risghospitalet,
Copenhagen, Denmark, 2100